Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sayali Karve"'
Autor:
Syed, Farhan A, Kassel Fotinos-Hoyer, O'connor, Michael, Li, Maureen, Hermannsson, Bryan, Enus, Nicholas, Sayali Karve, Sharma, Manish, Pradella, Gabriele, Landewé, Robert B M, Baraliakos, Xenofon, Warner, Sarah
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39bf9b0787ab042d314b22ab3fd1e65b
Autor:
Arvin Kheterpal, Rudresh Jarecha, Joseph Mikhael, Jayant Narang, Surabhi Bajpai, Katarina Ludajic, Sayali Karve
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e192-e193
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bdc8cfc3094d3d7bf835c6fbf541394
https://doi.org/10.1016/j.clml.2019.09.321
https://doi.org/10.1016/j.clml.2019.09.321
Autor:
Rudresh Jarecha, Sayali Karve, Michael D O'Connor, Shweta Narang, Manish Sharma, Katarina Ludajic, Jayant Narang, Surabhi Bajpai
Publikováno v:
Blood. 134:5277-5277
Background: The Lugano classification criteria introduced in 2014 is widely used in clinical trials as well as in clinical practice for response assessment in Lymphoma. The criteria recommend a combination of disease morphology assessment using Compu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::998bfb6ca4101d0c1006866b225b4d19
https://doi.org/10.1182/blood-2019-130570
https://doi.org/10.1182/blood-2019-130570
Autor:
Katarina Ludajic, Rudresh Jarecha, Surabhi Bajpai, Manish Sharma, Sayali Karve, Oliver Bohnsack, Jayant Narang
Publikováno v:
Journal of Clinical Oncology. 37:e19015-e19015
e19015 Background: Revised Response Criteria in Malignant Lymphoma (Cheson 2007) and Lugano Classification are the most commonly used guidelines to assess response to treatment in lymphoma in clinical trials. While not drastically different from Ches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c76418599d25e109f8431d541e67268
https://doi.org/10.1200/jco.2019.37.15_suppl.e19015
https://doi.org/10.1200/jco.2019.37.15_suppl.e19015
Autor:
Yibin Shao, Oliver Bohnsack, A. Kassel Fotinos-Hoyer, Manish Sharma, Michael D O'Connor, Sayali Karve, Nicholas Enus
Publikováno v:
Journal of Clinical Oncology. 37:e18082-e18082
e18082 Background: Double read with adjudication is a preferred independent review model of regulatory authorities for blinded independent central review (BICR) in order to minimize reviewer bias in clinical trials. Adjudication rate (AR) and adjudic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9228ede0b4d5060c4129b0414e586240
https://doi.org/10.1200/jco.2019.37.15_suppl.e18082
https://doi.org/10.1200/jco.2019.37.15_suppl.e18082
Autor:
Sayali Karve, Alpana Harisinghani, Rohit Sood, Ramanaidu Darapureddi, Michael D O'Connor, Sanjeev Pitla, Shobitha Manikandan, Manish Sharma
Publikováno v:
Blood. 132:5472-5472
Background: Splenomegaly is one of the most characteristic features of myelofibrosis (MF) with significant impact on the quality of life of patients. About 10% of MF patients present with severely symptomatic splenomegaly at diagnosis; another 50% de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b9e46c18f28a3f9fd85303e0002a09b
https://doi.org/10.1182/blood-2018-99-118402
https://doi.org/10.1182/blood-2018-99-118402
Autor:
Manish Sharma, Nicholas Enus, A. Kassel Fotinos-Hoyer, Anitha Singareddy, Sayali Karve, Michael D O'Connor, Daniel Clark
Publikováno v:
Journal of Clinical Oncology. 36:e18594-e18594
e18594Background: With PFS as a primary endpoint, the assessment of Progressive Disease (PD) is the single most important trial assessment. As such, in blinded independent central review (BICR) uti...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d34656ac646dd12881eb5b089d6581a7
https://doi.org/10.1200/jco.2018.36.15_suppl.e18594
https://doi.org/10.1200/jco.2018.36.15_suppl.e18594
Autor:
Sayali Karve, Manish Sharma, Anitha Singareddy, Daniel Clark, A. Kassel Fotinos-Hoyer, Nicholas Enus, Michael O'Connor
Publikováno v:
Journal of Clinical Oncology. 36:e18592-e18592
e18592Background: Blinded independent central review utilizing double read with adjudication is a preferred model by regulatory authorities to minimize reader bias in clinical trials. Monitoring of...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5055f3e9956c734f4a8d25ad0b51b4c
https://doi.org/10.1200/jco.2018.36.15_suppl.e18592
https://doi.org/10.1200/jco.2018.36.15_suppl.e18592